Author: Vanessa Ngan, Staff Writer, 2004.
Gardner syndrome is a variant of ‘familial adenomatous polyposis’ (FAP), an inherited disease that is characterised by gastrointestinal polyps, multiple osteomas (benign bone tumours), and skin and soft tissue tumours. Polyps tend to form at puberty with the average age of diagnosis around 25 years of age. In almost all patients, polyps will progress to malignancy, resulting in colorectal cancer so that timely detection is essential.
Gardner Syndrome is due to mutations on the APC gene on chromosome 5q22. The gene plays a role in tumour suppression. Gardner syndrome is inherited as an autosomal dominant trait, so that an affected person has a 50% chance of passing on the gene to each of their children.
Clinical features of Gardner syndrome can be divided into two types, cutaneous and non-cutaneous. The most noticeable cutaneous feature of Gardner syndrome is the appearance of epidermoid cysts. These cysts can be differentiated from ordinary epidermoid cysts by the following factors:
Non-cutaneous features include:
Radiological studies are essential for patients and family members with suspected Gardner syndrome.
Treatment of epidermoid cysts in Gardner syndrome is similar to that used for ordinary cysts and involves excision. Occasionally intralesional steroid injections may be used if the cysts are inflamed.
Surgical removal of gastrointestinal polyps is recommended because of the very high risk of polyps developing into cancer. Patients need regular colonoscopies.
Osteomas may also require excision only if they are severely deforming or if they are a nuisance.
See the DermNet NZ bookstore
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.